| Literature DB >> 27474742 |
Robert J Andrew1, Katherine A B Kellett2, Gopal Thinakaran3, Nigel M Hooper4.
Abstract
Proteolysis of the amyloid precursor protein (APP) liberates various fragments including the proposed initiator of Alzheimer disease-associated dysfunctions, amyloid-β. However, recent evidence suggests that the accepted view of APP proteolysis by the canonical α-, β-, and γ-secretases is simplistic, with the discovery of a number of novel APP secretases (including δ- and η-secretases, alternative β-secretases) and additional metabolites, some of which may also cause synaptic dysfunction. Furthermore, various proteins have been identified that interact with APP and modulate its cleavage by the secretases. Here, we give an overview of the increasingly complex picture of APP proteolysis.Entities:
Keywords: ADAM; ADAM10; Alzheimer disease; amyloid; amyloid precursor protein (APP); amyloid-beta (AB); beta-secretase 1 (BACE1); cathepsin B (CTSB); presenilin; protease; proteolysis; secretase
Mesh:
Substances:
Year: 2016 PMID: 27474742 PMCID: PMC5016663 DOI: 10.1074/jbc.R116.746032
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157